Notícias Eulerpool Innovent Biologics

Innovent Biologics Eulerpool-AFX

Innovent Biologics Notícias de ações

Innovent Biologics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Innovent Biologics nós reunimos aqui.

• 11 de setembro ·

  Yahoo
  Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC
• 10 de setembro ·

  Yahoo
  Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation
• 9 de setembro ·

  Yahoo
  High Growth Tech Stocks to Watch in Hong Kong September 2024
• 9 de setembro ·

  Yahoo
  SEHK Value Picks That Could Be Undervalued In September 2024
• 9 de setembro ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring 3 Prominent Picks
• 4 de setembro ·

  Yahoo
  FDA grants fast track status to Innovent’s IBI363 for melanoma
• 4 de setembro ·

  Yahoo
  Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma
• 2 de setembro ·

  Yahoo
  Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024
• 29 de agosto ·

  Yahoo
  Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024
• 28 de agosto ·

  Yahoo
  Innovent Announces 2024 Interim Results and Business Updates